<code id='128BD01B06'></code><style id='128BD01B06'></style>
    • <acronym id='128BD01B06'></acronym>
      <center id='128BD01B06'><center id='128BD01B06'><tfoot id='128BD01B06'></tfoot></center><abbr id='128BD01B06'><dir id='128BD01B06'><tfoot id='128BD01B06'></tfoot><noframes id='128BD01B06'>

    • <optgroup id='128BD01B06'><strike id='128BD01B06'><sup id='128BD01B06'></sup></strike><code id='128BD01B06'></code></optgroup>
        1. <b id='128BD01B06'><label id='128BD01B06'><select id='128BD01B06'><dt id='128BD01B06'><span id='128BD01B06'></span></dt></select></label></b><u id='128BD01B06'></u>
          <i id='128BD01B06'><strike id='128BD01B06'><tt id='128BD01B06'><pre id='128BD01B06'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:796
          Two doctors operate a phone and a laptop next to stacks of cloud files — in the lab coverage from STAT
          Adobe

          Usually the words generative AI in health are followed by a bold claim. The technology will transform some aspect of care delivery, save gobs of money, or automate administrative tasks crucial to connecting patients with timely services.

          Rohit Chandra, chief digital officer of the Cleveland Clinic, said generative AI can accomplish all these things. But he also said this:

          advertisement

          “Harm is not just likely. It is for sure going to happen.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          David Sabatini, ex
          David Sabatini, ex

          WikimediaCommonsFormerMITandWhiteheadInstitutestarbiologistDavidSabatini,wholosthispositionsafterhew

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Merck drug for rare lung condition set for approval in U.S.

          AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona